次スレもココなんだろ? 売られて株価が下がっても笑って語尾につけて煽るんだろ? 0332山師さん@トレード中2020/06/11(木) 01:34:08.64ID:w7AwVq9+d だれもここみて買ってないけど 0333山師さん@トレード中2020/06/11(木) 06:00:20.99ID:ScqGPXrl0 ※Gowling WLG: "Gowling WLG Partner Patrick Duxbury Receives Award at LMG European Life Sciences Awards 2020". (6/10) 10 June 2020 Gowling WLG's head of life sciences, Patrick Duxbury, has been named 'Financial & Corporate Lawyer of the Year: Licensing & Collaboration' in the LMG European Life Sciences Awards 2020, announced today. The LMG Life Sciences Awards are presented to firms, individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as those driving the international market. Patrick's achievement highlights his expertise and strong reputation in the life sciences sector. In the past year, he has led on a number of high-profile deals, which include advising long-standing client AstraZeneca on a landmark collaboration agreement for the development and distribution of the University of Oxford's potential COVID-19 vaccine. He also led on a $6.9 billion cancer drug collaboration agreement for AstraZeneca with Daiichi Sankyo Company, Limited and a US$1 billion dollar drug research collaboration and licensing agreement for Sosei Heptares with Genentech. Originally, a microbiologist and geneticist before requalifying as a lawyer in 1993, Patrick specialises in all aspects of transactional work in the life sciences sector. He is a 'leading individual' in Legal 500 2020, named a Who's Who Legal Award winner in 2019 and is both a well-known speaker in life sciences and teaches on the BIO Advanced Business Development Course in both the US and Europe. Gowling WLG's global Life Sciences team combines extensive sector expertise with full-service capability. With a reputation for being "excellent for corporate and investment transactions" and "complex licence, research and collaboration agreements" (Chambers UK 2019), its clients range from global pharmaceutical companies and leading research and academic bodies, to small private companies and start-up businesses. 0334山師さん@トレード中2020/06/11(木) 06:18:37.82ID:DWVCBrAX0 個人が多いから狙い撃ちされる罠 売買のツイとか見てるとマジ呆れる 0335山師さん@トレード中2020/06/11(木) 06:55:31.40ID:GlkXxbg4d 個人が多いと上がるな アンジェスやテラみたらわかる 個人に人気ないここ 0336山師さん@トレード中2020/06/11(木) 07:28:48.98ID:aNVQAf/Y0 ちょい待って下さいよぉ… 0337山師さん@トレード中2020/06/11(木) 07:37:01.05ID:3Ig+KmrD0 Mはもうアナウンス無いだろうな 0338山師さん@トレード中2020/06/11(木) 07:58:24.23ID:6IQ04BD60 気配大暴落ww 空売り外資様、野村様を舐めんなよ 0339山師さん@トレード中2020/06/11(木) 08:19:58.63ID:FVC7ZPwY0>>335 なんでここってこんなに個人に人気無いの? aHoo掲示板のせいですかね? 0340山師さん@トレード中2020/06/11(木) 08:24:56.24ID:BEKjNY5nd 裏切り続けたからだよ、M1も去年から散々悪い様にはならないし期待してて下さいって言い続けてるからなw それで駄目ならやっぱりまたかよってなる。 0341山師さん@トレード中2020/06/11(木) 08:29:38.67ID:6LVUuFE70 朝からルサンチメンズが注視する銘柄w 0342山師さん@トレード中2020/06/11(木) 08:45:55.86ID:/Mmf/oK+M もうмシリーズは戦力外だわな